Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors

International Journal of Gynecological Pathology

Volumn 16, Issue 1, 1997, Pages 60-68

  Niikura, Hitoshi ^a   Sasano, Hironobu ^a   Sato, Shinji ^b   Yajima, Akira ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE

Author keywords

Carcinoma; EGF family; EGFR; Immunohistochemistry Ovary

Indexed keywords

AMPHIREGULIN; CISPLATIN; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; TRANSFORMING GROWTH FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CYSTADENOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUCINOUS CARCINOMA; OVARY ADENOCARCINOMA; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0030905266     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004347-199701000-00010     Document Type: Article

References (25)

1. Derynck R, Goeddel DV, Ullrich A, Gutterman R, Bringman T. Synthesis of messenger RNAs for transforming growth factor α and the epidermal growth factor receptor by human tumors. Cancer Res 1987;47:707-12.
2. Di Marco E, Pierce JH, Fleming YP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP. Autocrine interaction between TGF-α and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 1989;4:831-8.
3. Umekita Y, Enokizono N, Sagara Y, Kuriwaki K, Takasaki T, Yoshida A, Yoshida H. Immunohistochemical studies on oncogene products (EGF-R, c-erbB-2) and growth factors (EGF, TGF-α) in human breast cancer: their relationship to oestrogen receptor status, histological grade, mitotic index and nodal status. Virchows Archiv A Pathol Anat 1992;420:345-51.
4. Cohen S. Isolation of a submaxillary gland protein accelerating incisor eruption and eyelid opening in the newborn animal. J Biol Chem 1962;137:1555-62.
5. Carpenter G. Epidermal growth factor. Handb Exp Pharmacol 1981;57:90-126.
6. Derynck R. Transforming growth factor-α. Cell 1988;54:593-5.
7. Syoyab M, Plowman GD, McDonald VL, Bradly J, Todaro GJ. Structure and function of human amphiregulin; a member of the epidermal growth factor family. Science 1989;243:1074-6.
8. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsburn M. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 1991;251:936-9.
9. Ciccodicola A, Dono R, Obici S, Simeone A, Zollo M, Persico GM. Molecular characterization of a gene of the 'EGF family' expressed in undifferentiated human NTERA2 teratocarcinoma cells. EMBO J 1989;8:1987-91.
10. Ushiro H, Cohen S. Identification of phosphothyrosin as a product of epidermal growth factor activated protein kinase in A-431 cell membranes. J Biol Chem 1980;225:8263-5.
11. Adamson ED, Rees AR. Epidermal growth factor receptors. Mol Cell Biochem 1981;34:129-52.
12. Velu TJ. Structure, function, and transforming potential of the epidermal growth factor receptor. Mol Cell Endocrinol 1990;70: 205-16.
13. Morishige K, Kurachi H, Amemiya K, Fujita Y, Yamamoto T, Miyake A, Tanizawa O. Evidence for the involvement of transforming growth factor alpha and epidermal growth factor receptor autocrine growth mechanism in primary human ovarian cancers in vitro. Cancer Res 1991;51:5322-8.
14. Morishige K, Kurachi H, Amemiya K, Adachi H, Inoue M, Miyake A, Tanizawa O, Sakoyama Y. Involvement of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vitro Cancer Res 1991;51:5951-5.
15. Kurachi H, Morishige K, Amemiya K, Adachi H, Hirota K, Miyake A, Tnizawa O. Importance of transforming growth factor alpha/epidermal growth factor receptor autocrine growth mechanism in an ovarian cancer cell line in vivo. Cancer Res 1991;51: 5956-9.
16. Bauknecht T, Birmelin G, Kommoss F. Clinical significance of oncogenes and growth factors in ovarian carcinomas. J Steroid Biochem Mol Biol 1990;37:855-62.
17. Bauknecht T, Angel P, Kohler M, Kommoss F, Birmelin G, Pfleiderer A, Wagner E. Gene structure and expression analysis of the epidermal growth factor receptor, transforming growth factor -alpha, myc, jun, and metallothionein in human ovarian carcinomas. Cancer 1993;71:419-29.
18. Stromberg K, Johnson GR, O'Connor DM, Sorensen CM, Gullick WJ, Kanan B. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis. Int J Gynecol Pathol 1994;13:342-7.
19. Ehrlich CE, Einhorn L, Williams SD, Morgan J. Chemotherapy for stage III-IV epithelial ovarian cancer with cis-dichlorodiammineplatinum (II), adriamycin, and cyclophosphamide: a preliminary report. Cancer Treat Rep 1979;63:281-8.
20. Omura G, Blessing JA, Ehrlich CE, Miller A, Yordan E, Creasman WT, Homesley HD. A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma. Cancer 1986;57:1725-30.
21. The new FIGO stage grouping for primary carcinoma of the ovary. Gynecol Oncol 1986;25:383-5.
22. Sasano H, Suzuki T, Shizawa S, Kato K, Nagura H. Transforming growth factor α, epidermal growth factor, and epidermal growth factor receptor expression in normal and diseased human adrenal cortex by immunohistochemistry and in situ hybridization. Mod Pathol 1994;7:741-6.
23. Akiyana S, Fojo A, Hanover J, Pastan I, Gottesman M. Isolation and genetic characterization of human KB cell line resistant to multiple drug. Somat Cell Mol Genet 1985;11:117-26.
24. Fojo A, Ueda K, Slamon D, Poplack D, Gottesman M, Pastan I. Expression of a multidrug-resistant gene in human tumors and tissues. Proc Natl Acad Sci USA 1987;84:265-9.
25. Cornwell MM, Smith DE. A signal transduction pathway for activation of mdr1 promoter involves the proto-oncogene c-raf kinase. J Biol Chem 1993;268:15347-50.